PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

The Diversity Dearth in Pharma

Europe's Disclosure D-Day Draws Near

SWSX 2016 & The New Alchemy of Hope

Top Story
FDA Under Pressure to Revamp Off-Label Marketing Rules
In the decades since FDA established its rules governing what manufacturers can say about regulated products, the agency has not kept pace in updating its rules governing medical product promotion. Jill Wechsler looks at the consequences
... /Read more/
 
Advertisement
With the US healthcare industry in the midst of the largest transformation in its history, stakeholders must be aware of the latest challenges and opportunities. The upcoming FT US Healthcare & Life Sciences Summit on May 12 will focus on these emerging trends and explore what the future of healthcare might look like. Pharmaceutical Executive subscribers save 20% with the code FTPE20. Register here
 
Pricing
ACP’s Drug Cost Paper Ignores Economic Reality
The American College of Physicians chimed in on the debate surrounding prescription drug costs, offering its views for stemming the escalation. Ed Schoonveld offers a deep dive into the positions taken
... /Read more/
 
Advertisement
How On-Dose Technologies are Changing Pharmaceutical Product Intelligence and Security
On Demand
Read more
 
From the Editor
Medicines and Advertising: The Odd Couple
The challenges facing the ad industry and big Pharma are remarkably similar—a point driven home by four distinct themes discussed at this year’s 4A’s Transformation conference, writes William Looney
... /Read more/
SPONSORED
Global Innovators Gather in Philadelphia for DIA 2016
DIA 2016 is DIA's global annual meeting to advance health care product development around the world by connecting stakeholders to interdisciplinary insights and innovation
... /Read more/
Emerging Pharma Leaders
Pharm Exec’s Emerging Pharma Leaders 2016 — Nominate Now
Pharm Exec is looking for the fresh faces of pharma leadership. And we'd like your input. Tell us who you think should be included as one of our 2016 Emerging Pharma Leaders. These leaders are vital to the future of the industry, and you can help ensure they get the recognition they deserve. Fill out your nomination today
... /Read more/
Opinion
Springtime for Pharma?
Even though the “dark days” for pharma are fading away, the chill of the last few months will not soon be forgotten. Tom Norton reviews where several key industry issues stand this spring after a winter season that can only be described as “difficult
... /Read more/
Calendar
/ May 12: FT Healthcare & Life Sciences Summit /
New York, NY
/ June 6–9: BIO International Convention /
San Francisco, CA.
/ June 21–22: Patient Engagement Solutions Summit /
Philadelphia, PA.
/ June 22–23: Global Medical Information and Communications Summit /
Barcelona, Spain.
/ August 15–17: 10th Annual Forum on Transparency and Aggregate Spend /
Washington, DC.
/ December 13–14: Life Sciences Trade and Channel Strategies /
Philadelphia, PA
 
Industry update
//Tris Pharma, Inc. (Monmouth Junction, NJ) appointed Sharon Clarke to the position of Chief Commercial Officer to lead Tris' brand business and launch its first commercial product.//Lumos Pharma, Inc. (Austin, TX) announced that David M. Weiner, M.D. has joined the company as Chief Medical Officer.//Autonomic Technologies, Inc. (Redwood City, CA) announced the appointment of Niamh Pellegrini to the position of President and Chief Executive Officer and member of its Board of Directors.//Immunovaccine Inc. (Halifax, Nova Scotia) named Acting Chief Executive Office Frederic Ors as permanent CEO. He and Andy Sheldon, President and CEO of Medicago, will be nominated to the Board of Directors at the company's AGM on April 14, and the Board will recommend their election.//Nuvo Pharmaceuticals Inc. (Mississauga, ON) announced that Jesse Ledger has been appointed to the newly created position of Vice President, Business Development.//
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com